Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Tenax Therapeutics Inc.

United States 101 Glen Lennox Drive Suite 300, 27517-4089, United States

About the sponsor

Tenax Therapeutics Inc. focuses on pulmonary hypertension in the setting of heart failure with preserved left ventricular ejection fraction, addressing a cardiopulmonary condition marked by impaired exercise capacity and elevated pulmonary pressures.

  • PH-HFpEF
  • Exercise Limitation
  • 6-Minute Walk Distance

The clinical program centers on improving functional status and evaluating treatment effects in patients with this overlapping cardiac and pulmonary vascular disorder.

About Specializations

Tenax Therapeutics Inc. runs clinical trials in conditions such as Pulmonary hypertension, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Pulmonary hypertension

Not yet recruiting

A study to evaluate the effectiveness of levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction.

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Levosimendan
  • Sponsor:Tenax Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.